Breast Cancer Oncotype Testing
Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy. Additional information: Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,
Buyer
Lincolnshire Partnership NHS Foundation Trust
Value
£490,050
Published
26 Apr 2024
Closes
11 Mar 2024
Procurement details
Source
Contracts Finder
Region
Lincolnshire
Procurement method
Selective
Category
Goods
Contract starts
12 Mar 2024
Contract ends
11 Mar 2027
CPV classifications
85111800
Pathology services
Lots
Lot default Breast Cancer Oncotype Testing
£490,050
Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy. Additional information: Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
26 Apr 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.